To buy shares in AbCellera Biologics Inc. you will need a US based stock trading platform like Interactive Brokers, eToro or Moomoo where it currently costs $2.55 to buy one share in AbCellera Biologics Inc. (as of 16:00 29-Apr-2025). Which is a change of $0.04 or -1.54% from the last closing price of $2.59.
How To Buy AbCellera Biologics Inc. Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in AbCellera Biologics Inc.:
- Pick a stock broker (jump down to compare the best brokers for buying AbCellera Biologics Inc. stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:ABCL)
- Choose the number of shares you want to buy (1 share currently costs $2.55)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your AbCellera Biologics Inc. stock in your account (this will show your profit and loss)
AbCellera Biologics Inc. Share Price (ABCL) Quote & Overview
This section shows the most important aspects of the current AbCellera Biologics Inc. ABCL:US share price including price, change, bid/offer spread and volume.
- AbCellera Biologics Inc. is currently worth $759,868,365 based on the last closing price of $2.59 with 3,401,123 shares traded.
- The most recent AbCellera Biologics Inc. daily high has been $2.63 and daily low $2.54.
- The AbCellera Biologics Inc. stock price 52 week high has been $4.34 and the 52 week low $1.89.
Compare Brokers For Buying AbCellera Biologics Inc. Stock
It’s usually commission-free to buy US stocks as American stock brokers make their money from payment for order flow. However, there can sometimes be additional charges for buying stocks in an IRA, where your contributions are tax-deductible.
| US Stock Broker | US Stocks Available | Dealing Commission | Margin Rates | Customer Reviews | More Info |
|---|---|---|---|---|---|
 | 17,913 | 0.003% | 5.33% – 6.33% | (Based on 934 reviews)
| Visit Broker Your capital is at risk |
 | 6,000+ | 0% | 0% | (Based on 144 reviews)
| Visit Broker Your capital is at risk |
 | 5,000+ | 0% | 8% – 11% | (Based on 0 reviews)
| Read Reviews |
 | 4,000+ | 0% | 10.2% – 13.2% | (Based on 1 reviews)
| Read Reviews |
 | 4,000+ | 0% | 8.575% – 13.075% | (Based on 22 reviews)
| Read Reviews |
 | 5,000+ | 0% | 8% (Flat) | (Based on 23 reviews)
| Read Reviews |
 | 7,000+ | 0% | 8.5% – 12.075% | (Based on 0 reviews)
| Read Reviews |
 | 5,000+ | 0% | 9.49% (Flat) | (Based on 0 reviews)
| Read Reviews |
Is Now A Good Time To Buy AbCellera Biologics Inc. Stock?
For expert analysis join Good Money Guide Premium.
- AbCellera Biologics Inc.’s EPS (earnings per share) are 0.55. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- AbCellera Biologics Inc.’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below AbCellera Biologics Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.
AbCellera Biologics Inc. (ABCL) Analysis
This section shows analysis for AbCellera Biologics Inc. ABCL:US. It shows analyst rating, recommnedations and history, as well industry ranking comparison.
AbCellera Biologics Inc. (ABCL) Earnings Estimates & Forecasts
This section shows how analysts expect the AbCellera Biologics Inc. ABCL:US share price to perform in the future based on their earnings reports and estimates. It gives an overview of future short, long and medium term price targets as well as previous earnings reports.
AbCellera Biologics Inc. (ABCL) Company Financials
This section shows current and previous AbCellera Biologics Inc. ABCL:US profit and loss information like revenue, income, expenses and earnings per share.
AbCellera Biologics Inc. (ABCL) Financial Summary
This section allows you to compare AbCellera Biologics Inc. ABCL:US revenue, net income, cash flow statement and balance sheet against previous years. This can give you a good indication of how well a company is performing.
AbCellera Biologics Inc. (ABCL) Share Price History
This section provides a visual and table view of the historic AbCellera Biologics Inc. ABCL:US share price including volume and VWAP which can be adjusted for splits and dividends.
AbCellera Biologics Inc. (ABCL) Interactive Chart
This section allows you to compare AbCellera Biologics Inc. ABCL:US share price chart against other stocks as well as overlay key events like dividends, earnings and splits.
AbCellera Biologics Inc. (ABCL) Dividends
This section analyses the historic and upcoming AbCellera Biologics Inc. ABCL:US dividend amounts, dates and yields. It provides a good indication of potential future and past profitability.
AbCellera Biologics Inc. (ABCL) Corporate Events
This section shows key dates in AbCellera Biologics Inc. ABCL:US corporate calendar like company announcements, earnings releases, stock splits, and fundamental data chances like EPS updates.
AbCellera Biologics Inc. (ABCL) Share Price Performance
This section shows key AbCellera Biologics Inc. ABCL:US share price levels like recent highs and lows, plus gives you tools to see average day traded volumes and institutional share holders major buys and sells.
AbCellera Biologics Inc. (ABCL) Share Price News
This section shows new stories that are relevant to and may effect or explain changes in AbCellera Biologics Inc. ABCL:US share price.
AbCellera Biologics Inc. (ABCL) Company Profile
This section provides corporate information on AbCellera Biologics Inc. ABCL:US, including what they do, their contact details, their CEO and auditor as well as in what sectors their shares trade.
